CAS 1206170-62-8
:Formule :C17H20N6O
InChI :InChI=1S/C17H20N6O/c1-17(2,3)23-16-12(9-18)13(19)8-14(22-16)21-11-6-4-10(5-7-11)15(20)24/h4-8H,1-3H3,(H2,20,24)(H4,19,21,22,23)
Code InChI :XDEFNAWAKYQBQY-UHFFFAOYSA-N
SMILES :CC(C)(C)NC1=C(C(=CC(=N1)NC2=CC=C(C=C2)C(=O)N)N)C#N
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produits trouvés.
4-[[4-Amino-5-cyano-6-[(1,1-dimethylethyl)amino]-2-pyridinyl]amino]benzamide
CAS :4-[[4-Amino-5-cyano-6-[(1,1-dimethylethyl)amino]-2-pyridinyl]amino]benzamideFormule :C17H20N6ODegré de pureté :≥99%Masse moléculaire :324.384-[[4-Amino-5-cyano-6-[(1,1-dimethylethyl)amino]-2-pyridinyl]amino]benzamide
CAS :Degré de pureté :99%TC-Mps1-12
CAS :TC-Mps1-12 is an effective and selective inhibitor of monopolar spindle 1 (IC50: 6.4 nM) .Formule :C17H20N6ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :324.38TC-Mps1-12
CAS :TC-Mps1-12 is a drug target for skin cancer and bladder cancer. TC-Mps1-12 inhibits the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and its downstream signalling cascades, which are involved in cell proliferation. This drug has been shown to be effective in decreasing tumour size in mice with skin cancer. TC-Mps1-12 also inhibits the EGFR downstream signalling pathways in bladder cancer cells, leading to decreased production of inflammatory cytokines and increased apoptosis.Formule :C17H20N6ODegré de pureté :Min. 95%Masse moléculaire :324.38 g/mol
